![](/img/cover-not-exists.png)
Addition of Palbociclib to Adjuvant Endocrine Therapy Provides No Benefit
Nalley, CatlinVolume:
42
Journal:
Oncology Times
DOI:
10.1097/01.COT.0000721360.06586.4f
Date:
October, 2020
File:
PDF, 130 KB
2020